Home > Community > Patient News Feed > Nancy Bukowski

Nancy's Posts

Diagnosis: Bicuspid Aortic Valve, Mitral Regurgitation

Member Since: November 10, 2023

Send Nancy a Guestbook

My Posts

Nancy Bukowski posted an update

1 year ago (August 3, 2025)

https://consultqd.clevelandclinic.org/worlds-first-transcervical-robotic-avr-procedures

👍 Marvin Campos reacted to this

Nancy Bukowski

1 year ago (August 3, 2025)

Interesting article that I just saw posted.

Rose Madura

1 year ago (August 3, 2025)

That's amazing! Thanks for sharing.

Kathy Ozio

1 year ago (August 4, 2025)

Amazing!! Imagine heart surgery and only in the hospital for two days!

Grace Mason

1 year ago (August 5, 2025)

🤯

Nancy Bukowski posted an update

1 year ago (June 23, 2025)

Hello fellow Heart Warriors, I am one year post SAVR and aortic root enlargement due to a bicuspid aortic valve. Right after my surgery, my MR was mild. I just went for my one year echo and now my MR is moderate to severe. Ugh- I feel like this rollercoaster... Read more.

Rose Madura

1 year ago (June 23, 2025)

Nancy, I'm sorry to hear this. I hope you can get some solid answers soon. Stay strong. Please keep us posted. ❤️🩹

Susan Lynn

1 year ago (June 24, 2025)

Nancy - Good luck, tomorrow. Please keep us posted. We'll be sending you positive thoughts!

Nancy Bukowski

1 year ago (June 24, 2025)

Thank you, Rose and Susan, for the words of encouragement. I could use some right now. I will keep you posted-hoping for the best!

Nancy Bukowski posted an update

2 years ago (March 31, 2024)

Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis

https://news.medtronic.com/2024-03-27-Medtronic-announces-FDA-approval-of-newest-generation-Evolut-TAVR-system-for-treatment-of-symptomatic-severe-aortic-stenosis

The Evolut™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access DUBLIN, March 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE:...